HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
25 hedge funds and large institutions have $3.61M invested in Hepion Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
5
Closed
7
Calls
$97K
Puts
$8K
Net Calls
+$89K
Net Calls Change
-$45K
Top Buyers
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$235K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$26K |
| 3 |
Jane Street
New York
|
-$23K |
| 4 |
BlackRock
New York
|
-$11.1K |
| 5 |
Two Sigma Advisers
New York
|
-$8K |
